Getinge’s Maquet Grows In Cardiology And Elsewhere With Atrium Buy
This article was originally published in The Gray Sheet
Executive Summary
Swedish conglomerate Getinge Group is buying diversified device firm Atrium Medical for $680 million in a move that will expand its cardiovascular device business while adding new areas such as biosurgery and thoracic drainage products.
You may also be interested in...
Getinge Resumes Cardiovascular Shopping Spree With Datascope Purchase
Getinge is continuing to solidify its position in the cardiovascular device market with its $865 million acquisition of intra-aortic balloon pump maker Datascope, announced Sept. 16
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.